This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Guardion Health Sciences Stock (NASDAQ:GHSI) 30 days 90 days 365 days Advanced Chart Get GHSI alerts:Sign Up Key Stats Today's Range$3.22▼$3.2950-Day Range$3.22▼$3.5052-Week Range$3.04▼$18.00Volume4,700 shsAverage Volume105,261 shsMarket Capitalization$4.35 millionP/E Ratio0.66Dividend Yield155.28%Price TargetN/AConsensus RatingN/A Company OverviewGuardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More… Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GHSI Stock News HeadlinesGuardion Health Sciences Announces Declaration of Cash DistributionDecember 23, 2024 | globenewswire.comGuardion Health Sciences Announces Filing of Certificate of DissolutionOctober 30, 2024 | globenewswire.comSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.May 2, 2025 | Stansberry Research (Ad)Guardion Health Sciences Announces Delisting and New Interim CEOOctober 5, 2024 | finance.yahoo.comGuardion Health Sciences Inc (GHSI)October 3, 2024 | investing.comGuardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, PresidentOctober 1, 2024 | marketwatch.comGuardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEOOctober 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences (GHSI) Stock Is Getting HammeredOctober 1, 2024 | msn.comSee More Headlines GHSI Stock Analysis - Frequently Asked Questions How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) announced its earnings results on Monday, August, 12th. The company reported ($42.00) earnings per share (EPS) for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 73.69% and a net margin of 22.79%. When did Guardion Health Sciences' stock split? Shares of Guardion Health Sciences reverse split before market open on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Acasti Pharma (ACST), iBio (IBIO) and GE Aerospace (GE). Company Calendar Last Earnings8/12/2019Today5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GHSI CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees10Year Founded2009Profitability EPS (Most Recent Fiscal Year)$4.87 Trailing P/E Ratio0.66 Forward P/E RatioN/A P/E GrowthN/ANet Income$160,000.00 Net Margins22.79% Pretax Margin-20.29% Return on Equity-73.69% Return on Assets-48.17% Debt Debt-to-Equity RatioN/A Current Ratio16.68 Quick Ratio16.59 Sales & Book Value Annual Sales$12.25 million Price / Sales0.35 Cash Flow$0.14 per share Price / Cash Flow23.15 Book Value$6.39 per share Price / Book0.50Miscellaneous Outstanding Shares1,350,000Free Float1,332,000Market Cap$4.35 million OptionableNot Optionable Beta0.73 Social Links 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free Report This page (NASDAQ:GHSI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardion Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.